Vascular skin symptoms in COVID‐19: a French observational study

Coronavirus 19 (COVID‐19) was declared as a pandemic viral infection by the World Health organization on March 11th 2020. Usual clinical manifestations of COVID‐19 infection include fever, fatigue, myalgia, headache, diarrhea, dry cough, dyspnea that may lead to acute respiratory distress syndrome a...

Full description

Saved in:
Bibliographic Details
Published inJournal of the European Academy of Dermatology and Venereology Vol. 34; no. 9; pp. e451 - e452
Main Authors Bouaziz, J.D., Duong, T.A., Jachiet, M., Velter, C., Lestang, P., Cassius, C., Arsouze, A., Domergue Than Trong, E, Bagot, M., Begon, E., Sulimovic, L., Rybojad, M
Format Journal Article Web Resource
LanguageEnglish
Published England John Wiley & Sons, Inc 01.09.2020
John Wiley and Sons Inc
Subjects
COVID-19 - complications
COVID-19 - virology
Covid‐19 Special Forum
France
Humans
Letter To The Editor
SARS-CoV-2 - isolation & purification
Skin Diseases, Vascular - complications
France
Online AccessGet full text

Cover

More Information
Summary:Coronavirus 19 (COVID‐19) was declared as a pandemic viral infection by the World Health organization on March 11th 2020. Usual clinical manifestations of COVID‐19 infection include fever, fatigue, myalgia, headache, diarrhea, dry cough, dyspnea that may lead to acute respiratory distress syndrome and death (1). Skin symptoms of COVID‐19 have been poorly described but may include erythematous rash, urticaria and chicken pox like lesions (2‐7). Angiotensin‐converting enzyme 2 (ACE2) is a cellular receptor for COVID‐19.
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ObjectType-Undefined-2
ISSN:0926-9959
1468-3083
DOI:10.1111/jdv.16544